These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21319282)

  • 1. Impact of chemotherapy on disseminated low-grade glioma in children and adolescents: report from the HIT-LGG 1996 trial.
    von Hornstein S; Kortmann RD; Pietsch T; Emser A; Warmuth-Metz M; Soerensen N; Straeter R; Graf N; Thieme B; Gnekow AK
    Pediatr Blood Cancer; 2011 Jul; 56(7):1046-54. PubMed ID: 21319282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
    Gnekow AK; Kortmann RD; Pietsch T; Emser A
    Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HIT-LGG: effectiveness of carboplatin-vincristine in progressive low-grade gliomas of childhood--an interim report].
    Gnekow AK; Kaatsch P; Kortmann R; Wiestler OD
    Klin Padiatr; 2000; 212(4):177-84. PubMed ID: 10994547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945.
    Fouladi M; Hunt DL; Pollack IF; Dueckers G; Burger PC; Becker LE; Yates AJ; Gilles FH; Davis RL; Boyett JM; Finlay JL
    Cancer; 2003 Sep; 98(6):1243-52. PubMed ID: 12973849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology.
    Gnekow AK; Falkenstein F; von Hornstein S; Zwiener I; Berkefeld S; Bison B; Warmuth-Metz M; Driever PH; Soerensen N; Kortmann RD; Pietsch T; Faldum A
    Neuro Oncol; 2012 Oct; 14(10):1265-84. PubMed ID: 22942186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
    Geyer JR; Sposto R; Jennings M; Boyett JM; Axtell RA; Breiger D; Broxson E; Donahue B; Finlay JL; Goldwein JW; Heier LA; Johnson D; Mazewski C; Miller DC; Packer R; Puccetti D; Radcliffe J; Tao ML; Shiminski-Maher T;
    J Clin Oncol; 2005 Oct; 23(30):7621-31. PubMed ID: 16234523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANZCCSG BabyBrain99; intensified systemic chemotherapy, second look surgery and involved field radiation in young children with central nervous system malignancy.
    Bandopadhayay P; Hassall TE; Rosenfeld JV; Wheeler GC; Downie PA; Kirby ML; Cohn RJ; Sullivan MJ; Ashley DM
    Pediatr Blood Cancer; 2011 Jul; 56(7):1055-61. PubMed ID: 21298769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity-modulated radiotherapy (IMRT) in pediatric low-grade glioma.
    Paulino AC; Mazloom A; Terashima K; Su J; Adesina AM; Okcu MF; Teh BS; Chintagumpala M
    Cancer; 2013 Jul; 119(14):2654-9. PubMed ID: 23633429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-grade glioma in children under 5 years of age: a chemotherapy only approach with the BBSFOP protocol.
    Dufour C; Grill J; Lellouch-Tubiana A; Puget S; Chastagner P; Frappaz D; Doz F; Pichon F; Plantaz D; Gentet JC; Raquin MA; Kalifa C
    Eur J Cancer; 2006 Nov; 42(17):2939-45. PubMed ID: 16962317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vincristine and carboplatin chemotherapy for unresectable and/or recurrent low-grade astrocytoma of the brainstem.
    Ronghe M; Hargrave D; Bartels U; Tabori U; Vaidya S; Chandler C; Kulkarni A; Bouffet E
    Pediatr Blood Cancer; 2010 Sep; 55(3):471-7. PubMed ID: 20535831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and efficacy of repeated chemotherapy for progressive pediatric low-grade gliomas.
    Scheinemann K; Bartels U; Tsangaris E; Hawkins C; Huang A; Dirks P; Fried I; Bouffet E; Tabori U
    Pediatr Blood Cancer; 2011 Jul; 57(1):84-8. PubMed ID: 21557457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Children <1 year show an inferior outcome when treated according to the traditional LGG treatment strategy: a report from the German multicenter trial HIT-LGG 1996 for children with low grade glioma (LGG).
    Mirow C; Pietsch T; Berkefeld S; Kwiecien R; Warmuth-Metz M; Falkenstein F; Diehl B; von Hornstein S; Gnekow AK
    Pediatr Blood Cancer; 2014 Mar; 61(3):457-63. PubMed ID: 24039013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part II: Treatment-related late toxicity.
    Kortmann RD; Timmermann B; Taylor RE; Scarzello G; Plasswilm L; Paulsen F; Jeremic B; Gnekow AK; Dieckmann K; Kay S; Bamberg M
    Strahlenther Onkol; 2003 Sep; 179(9):585-97. PubMed ID: 14628124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
    Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
    Kortmann RD; Jeremic B; Weller M; Plasswilm L; Bamberg M
    Strahlenther Onkol; 2003 Apr; 179(4):219-32. PubMed ID: 12707711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboplatin hypersensitivity reaction in pediatric patients with low-grade glioma: a Canadian Pediatric Brain Tumor Consortium experience.
    Lafay-Cousin L; Sung L; Carret AS; Hukin J; Wilson B; Johnston DL; Zelcer S; Silva M; Odame I; Mpofu C; Strother D; Bouffet E
    Cancer; 2008 Feb; 112(4):892-9. PubMed ID: 18098210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy plus concurrent and adjuvant procarbazine, lomustine, and vincristine chemotherapy for patients with malignant glioma.
    Yang SH; Hong YK; Yoon SC; Kim BS; Lee YS; Lee TK; Lee KS; Jeun SS; Kim MC; Park CK
    Oncol Rep; 2007 Jun; 17(6):1359-64. PubMed ID: 17487391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of centrally located low-grade glioma in children.
    Terashima K; Chow K; Jones J; Ahern C; Jo E; Ellezam B; Paulino AC; Okcu MF; Su J; Adesina A; Mahajan A; Dauser R; Whitehead W; Lau C; Chintagumpala M
    Cancer; 2013 Jul; 119(14):2630-8. PubMed ID: 23625612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy.
    Jennings MT; Cmelak A; Johnson MD; Moots PL; Pais R; Shyr Y
    Pediatr Blood Cancer; 2004 Jul; 43(1):46-54. PubMed ID: 15170889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HIT-GBM: multicenter study of treatment of children with malignant glioma].
    Wolff JE; Boos J; Kühl J
    Klin Padiatr; 1996; 208(4):193-6. PubMed ID: 8926684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.